Remission InductionRemission, SpontaneousPostoperative ComplicationsTreatment OutcomeRetrospective StudiesRecurrenceFollow-Up StudiesIntraoperative ComplicationsTime FactorsProspective StudiesCytarabineAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteCombined Modality TherapyPrognosisCyclophosphamideDiabetes ComplicationsRisk FactorsPrednisoneVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaPregnancy ComplicationsAcute DiseaseTransplantation, AutologousPrednisoloneSeverity of Illness IndexSurvival RateBone Marrow TransplantationDaunorubicinMethotrexateSurvival AnalysisReoperationImmunosuppressive AgentsTransplantation, HomologousDisease-Free SurvivalHematopoietic Stem Cell TransplantationDrug Therapy, CombinationColitis, UlcerativeNephrotic SyndromeLeukemia, LymphoidLeukemia, MyeloidDrug Administration ScheduleTomography, X-Ray ComputedMesalamineAntirheumatic AgentsNeoplasm, ResidualLength of StayCrohn DiseaseAntineoplastic AgentsDoxorubicinLaparoscopyIncidenceHemorrhageLeukemiaAntibodies, Monoclonal, Murine-DerivedObstetric Labor ComplicationsAsparaginaseBone MarrowSurgical Wound InfectionCohort StudiesRisk AssessmentSalvage TherapyEtoposideLymphoma, Non-Hodgkin6-MercaptopurineThioguanineHodgkin DiseaseEquipment FailureLeukemia, Promyelocytic, AcuteArthritis, RheumatoidAntibodies, MonoclonalIdarubicinDevice RemovalFatal OutcomeEndoscopyAge FactorsDrainageDisease ProgressionPregnancyForeign-Body MigrationGraft vs Host DiseaseFeasibility StudiesSurgical Wound DehiscencePredictive Value of TestsCatheterizationPostoperative HemorrhageInfectionInfant, NewbornCatheters, IndwellingDepressive Disorder, MajorPostoperative CareNeoplasm Recurrence, LocalTransplantation ConditioningPituitary ACTH HypersecretionHematomaAnti-Inflammatory AgentsStentsClinical Trials as TopicGastrointestinal AgentsTreatment Failure